GlassScriptPhysician profile
Marshall Jared Knauer
NPI 1043505860
$16,679.04
in general payments reported to CMS, 2019-2025
10 companies · $2,915 in 2025
The $2,915 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $419 · 2021: $85.00 · 2022: $329 · 2023: $5,203 · 2024: $7,464 · 2025: $2,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $15K · Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $15,430.15 |
| Food and Beverage | $151.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $15,269.14 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $415.17 | 2020-2021 | |
| Premier Dental Products Company | $317.10 | 2021-2024 | Slix Ipc |
| Ultradent Products INC | $279.00 | 2022 | |
| Straumann USA LLC | $250.00 | 2019 | |
| Septodont INC. | $54.01 | 2020 | |
| Essential Dental Systems Incorporated | $49.54 | 2022 | |
| Zimvie INC. | $16.22 | 2024 | |
| 3m Company | $14.48 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Knauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.